- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04233125
Core Decompression With or Without Cement Packing for ONFH
A Randomized Controlled Trial of Core Decompression With or Without Cement Packing for Osteonecrosis of the Femoral Head - Long Term Results
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A prospective randomized controlled trial comparing the results of CD vs. CD + PMMA packing in pre-collapse ONFH was set up.
Consecutive symptomatic patients aged >14 years with Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging were enrolled in this study.
Exclusion criteria were pre-existing collapse, sub-chondral fracture or degenerative changes of the hip.
After obtaining informed written consent, patients are asked to complete the Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and a health status questionnaire Short Form-36 (SF-36).
The femoral heads enrolled into the study are randomized using a computer-generated card draw system to one of following: core decompression (CD) or core decompression with PMMA cement packing (CD + PMMA).
Allocation concealment was practiced with the use of opaque envelopes. Patients with bilateral involvement who had been randomized to one treatment modality for one femoral head were automatically selected to receive the other treatment modality for the contralateral femoral head.
Blinding of either surgeon or patient is impossible.
The patients were followed up after surgery every 3-4 months for the first 2 years after which the patients were seen annually. Completed questionnaires and radiographs were obtained at each visit.
Statistical Analysis The date of index procedure (CD or CD + PMMA) was used as start date for the purpose of statistical analysis. Progression Free Survival was defined as the time to radiographic progression and Conversion Free Survival (CFS) as the time to a THA. In case of patients who did not have radiographic progression, the date of their last follow up or death was used for the analysis. The SAS software will be used for all the analyses. The Log rank and Gerhan-Wilcoxon tests were used to compare Kaplan-Meier survival curves for the time from the date of the index procedure to radiographic progression (subchondral collapse) or conversion to THA for separate groupings based on age at index procedure (<40 , >40 yrs), smoking (Y/N), location (central, medial, lateral), percent involvement (<15% [mild], 15% to 30% [moderate], or >30% [severe]), index of necrotic extent (<40 or >40), and modified index of necrotic extent (<40 or >40). Whenever factors were found to affect the survival curves mainly in the initial year the Gerhan-Wilcoxon test was used as the test of significance. The Kaplan-Meier curves were also compared for the main cohorts of CD vs. CD + PMMA. Cox proportional hazards regression was used to compare factors (age, smoking, location, percent involvement, index of necrotic extent, and modified index of necrotic extent) with regards to their ability to predict the time to progression or revision to THA. Mixed multilevel regression modeling was used to test for group differences in the change in self-rated health survey scores over time from baseline over the post-operative period. The hierarchical linear modeling approach has a number of advantages over traditional repeated measures approaches for modeling change over time, including allowance for missing data and for varying measurement times across subjects. Separate models were generated for SF-36, Harris Hip Score and WOMAC scores over two-year and over 5-year post-operative time periods.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging
Exclusion Criteria:
- pre-existing collapse, subchondral fracture or degenerative changes of the hip
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Core Decompression (CD) Only
Participants in this group receive standard care
|
Core Decompression
|
Experimental: Added Polymethylmethacrylate (PMMA)
Participants in this group receive standard care with an additional treatment
|
Core Decompression
Polymethylmethacrylate (PMMA) augmentation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Progression Free Survival (PFS)
Time Frame: 5 years
|
Progression Free Survival (PFS) is defined as the length of time (reported in months) following surgery that participants have no signs of radiographic progression of femoral head osteonecrosis.
Radiographic progression is defined as any degree of flattening or loss of spherical contour of the femoral head as detected on the radiographs or MRI.
Appearance of a subchondral fracture (crescent sign) on radiographs or MRI was also considered a sign of progression.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Conversion Free Survival (CFS)
Time Frame: 5 years
|
Conversion Free Survival (CFS) is defined as the length of time (reported in months) following surgery that participants are able to live without surgical conversion to total hip arthroplasty (THA).
|
5 years
|
Mean Harris Hip Score (HHS)
Time Frame: baseline, 2 years post surgery, 5 years post surgery
|
The Harris Hip Score (HHS) is a clinician-based instrument with 4 sub-scales measuring pain severity (44 points), function (47 points), absence of deformity (4 points), and range of motion (5 points).
Total score is calculated as a sum of 4 sub-scale scores and ranges from 0-100 with higher scores representing less dysfunction.
Three time points will be reported.
|
baseline, 2 years post surgery, 5 years post surgery
|
Change in Harris Hip Score (HHS)
Time Frame: baseline, 2 years post surgery
|
The Harris Hip Score (HHS) is a clinician-based instrument with 4 sub-scales measuring pain severity (44 points), function (47 points), absence of deformity (4 points), and range of motion (5 points).
Total score is calculated as a sum of 4 sub-scale scores and ranges from 0-100 with higher scores representing less dysfunction.
|
baseline, 2 years post surgery
|
Mean Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: baseline, 2 years post surgery, 5 years post surgery
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a self-administered questionnaire consisting of 24 items divided into 3 subscales: Pain (5 items), stiffness (2 items), and physical function (17 items).
Items are rated on a Likert scale of 0 (extreme) to 4 (none).
Raw sub-scale scores are normalized by multiplying each score by 100/96.
Total scores are a sum of the normalized sub-scales scores and range 0-100, with higher scores indicating better functioning.
Three time points will be reported.
|
baseline, 2 years post surgery, 5 years post surgery
|
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: baseline, 2 years post surgery
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a self-administered questionnaire consisting of 24 items divided into 3 subscales: Pain (5 items), stiffness (2 items), and physical function (17 items).
Items are rated on a Likert scale of 0 (extreme) to 4 (none).
Raw sub-scale scores are normalized by multiplying each score by 100/96.
Total scores are a sum of the normalized sub-scales scores and range 0-100, with higher scores indicating better functioning.
|
baseline, 2 years post surgery
|
Mean Short Form-36 (SF-36)
Time Frame: baseline, 2 years post surgery, 5 years post surgery
|
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health, containing 8 scaled sub-scores: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health.
Each sub-scale score is calculated as the weighted sum of the questions in that section, then directly transformed into a 0-100 score using a scoring algorithm.
The SF-36 also produces two summary scores, physical component summary and the mental component summary.
Lower scores indicated greater disability.
Three time points will be reported.
|
baseline, 2 years post surgery, 5 years post surgery
|
Change in Short Form-36 (SF-36)
Time Frame: baseline, 2 years post surgery
|
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health, containing 8 scaled sub-scores: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health.
Each sub-scale score is calculated as the weighted sum of the questions in that section, then directly transformed into a 0-100 score using a scoring algorithm.
The SF-36 also produces two summary scores, physical component summary and the mental component summary.
Lower scores indicated greater disability.
|
baseline, 2 years post surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9604M11032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteonecrosis
-
Catholic University of the Sacred HeartRecruitingOsteonecrosis of the Jaw | Bisphosphonate-Associated Osteonecrosis | Bisphosphonate-Associated Osteonecrosis of the Jaw | Osteonecrosis Due to Drugs, Jaw | Osteonecrosis Due to DrugItaly
-
McGill University Health Centre/Research Institute...UnknownOsteonecrosis of Femoral Head | Osteonecrosis; Aseptic, IdiopathicCanada
-
Fundació d'investigació Sanitària de les Illes...RecruitingOsteonecrosis of the Jaw, Bisphosphonate Induced | Osteonecrosis of the Jaw, Bisphosphonate RelatedSpain
-
University Hospital, ToulouseNot yet recruitingOsteonecrosis of the JawFrance
-
AmgenCompletedOsteonecrosis of the JawFrance, Germany, Italy, United States, Belgium, United Kingdom, Spain, Greece, Canada, Denmark, Finland
-
Red de Terapia CelularFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia and other collaboratorsUnknown
-
Kaohsiung Medical University Chung-Ho Memorial...National Taiwan University Hospital; Merck Sharp & Dohme LLC; National Cheng-Kung...UnknownNon-Traumatic OsteonecrosisTaiwan
-
Marmara UniversityRecruiting
-
Centre Hospitalier Sud FrancilienTerminatedOsteonecrosis Due to Drugs, JawFrance
-
Shiraz University of Medical SciencesShahid Beheshti University of Medical SciencesCompletedOsteonecrosis Due to Drugs, Jaw
Clinical Trials on Core Decompression
-
Guangdong Provincial People's HospitalUnknownAvascular Necrosis of Femur Head
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownBone Marrow | Avascular Necrosis of FemurTaiwan
-
Istituto Ortopedico RizzoliCompleted
-
Johns Hopkins UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsNot yet recruitingOsteonecrosis of the Femoral Head | Avascular Necrosis of the Femoral HeadUnited States
-
UCSF Benioff Children's Hospital OaklandCompletedSickle Cell Anemia | Bone Avascular NecrosisUnited States
-
Dante Dallari, MDCompletedHip Injuries | Hip NecrosisItaly
-
Aqua Medical Services (Pvt) LtdCompleted
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.ACompletedAvascular Necrosis of Femur HeadBelgium
-
National Taiwan University HospitalCompleted
-
University of LiegeCompletedNon Traumatic Osteonecrosis of the Femoral Head (Hip)Belgium